TRAVERE THERAPEUTICS, INC. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
TRAVERE THERAPEUTICS, INC. (TVTX) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 39.16 million shares for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-05.
Discontinued › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2017-05-05
- TRAVERE THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2017-03-31 was 39.16M shares, a 3.19% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2016-03-31 was 37.95M shares, a 17826.14% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2015-03-31 was 211.69K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 month |
|---|---|---|
| 2017-03-31 | 39.16M shares 10-Q · filed 2017-05-05 | |
| 2016-03-31 | 37.95M shares 10-Q · filed 2017-05-05 | |
| 2015-06-30 | 292.03K shares 10-Q · filed 2015-08-10 | |
| 2015-03-31 | 211.69K shares 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |